Search
for
Sort by
Research 781–810 of 1000+
- Metabolic Aspects of Polycystic Ovary Syndrome
- EMQN best practice guidelines for molecular genetic testing and reporting of 21-hydroxylase deficiency
- Follow-up of Nutritional and Metabolic Problems After Bariatric Surgery
- K channel therapeutics at the bedside
- HAIR REGROWTH
- Incidence of liver toxicity associated with the use of flutamide in prostate cancer patients
- The management of very low-calorie ketogenic diet in obesity outpatient clinic: a practical guide
- Polycystic Ovary Syndrome
- Physiology of the Hypothalamic Pituitary Gonadal Axis in the Male
- The role of nuclear hormone receptors in cutaneous wound repair
- Steroidal 5α-reductase and 17α-hydroxylase/17,20-lyase (CYP17) inhibitors useful in the treatment of prostatic diseases
- Nutrition Strategy and Life Style in Polycystic Ovary Syndrome—Narrative Review
- Regulation of masculinization: androgen signalling for external genitalia development
- Natural Molecules in the Management of Polycystic Ovary Syndrome (PCOS): An Analytical Review
- Sexuality in premature ovarian insufficiency
- Steroidogenic Isoenzymes in Human Hair and Their Potential Role in Androgenetic Alopecia
- Enzyme Replacement Therapy Ameliorates Multiple Symptoms of Murine Homocystinuria
- PCOS in Adolescence and Type 2 Diabetes
- Androgen antagonists in androgen target tissues
- Hair Loss and Hirsutism in the Elderly
- Pharmacologic Treatment of Polycystic Ovary Syndrome
- Androgenetic alopecia: combing the hair follicle signaling pathways for new therapeutic targets and more effective treatment options
- Chapter 17. Selective androgen receptor modulators (SARMs)
- Candidate SNP markers of reproductive potential are predicted by a significant change in the affinity of TATA-binding protein for human gene promoters
- Current aspects of polycystic ovary syndrome: A literature review
- Potential Medical Uses of Cannabigerol: A Brief Overview
- The Effect of Alfacalcidiol and Metformin on Phenotype Manifestations in Women with Polycystic Ovary Syndrome – a Preliminary Study
- Impact of Alpha Blockers, 5-alpha Reductase Inhibitors and Combination Therapy on Sexual Function
- Dermatologic manifestations of endocrine disorders
- Polycystic ovary syndrome